1. Home
  2. OBDC vs HAE Comparison

OBDC vs HAE Comparison

Compare OBDC & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blue Owl Capital Corporation

OBDC

Blue Owl Capital Corporation

N/A

Current Price

$10.48

Market Cap

5.0B

Sector

Finance

ML Signal

N/A

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

N/A

Current Price

$119.79

Market Cap

5.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OBDC
HAE
Founded
2015
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
5.4B
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
OBDC
HAE
Price
$10.48
$119.79
Analyst Decision
Buy
Buy
Analyst Count
13
11
Target Price
$13.10
★ $124.50
AVG Volume (30 Days)
★ 4.2M
673.9K
Earning Date
11-04-2026
11-05-2026
Dividend Yield
★ 11.93%
N/A
EPS Growth
★ N/A
N/A
EPS
0.08
★ 0.72
Revenue
N/A
★ $910,373,000.00
Revenue This Year
N/A
$6.21
Revenue Next Year
N/A
$5.54
P/E Ratio
★ $131.69
$167.21
Revenue Growth
★ N/A
N/A
52 Week Low
$9.81
$49.96
52 Week High
$13.58
$123.77

Technical Indicators

Market Signals
Indicator
OBDC
HAE
Relative Strength Index (RSI) 52.88 64.21
Support Level $9.81 $115.49
Resistance Level $11.37 $122.84
Average True Range (ATR) 0.22 2.86
MACD 0.09 -0.37
Stochastic Oscillator 83.06 70.15

Price Performance

Historical Comparison
OBDC
HAE

About OBDC Blue Owl Capital Corporation

Blue Owl Capital Corp is a specialty finance company and business development company (BDC) focused on providing direct lending solutions to U.S. middle-market companies. The company seeks to generate current income and, to a lesser extent, capital appreciation by targeting investment opportunities with favorable risk-adjusted returns, including senior secured, subordinated, or mezzanine loans and equity-related instruments. Its investment strategies are intended to generate favorable returns across credit cycles with an emphasis on preserving capital.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.

Share on Social Networks: